CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.

[1]  Yun Bian,et al.  Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma , 2019, Pancreas.

[2]  A. Grossman,et al.  What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1? , 2019, Clinical endocrinology.

[3]  Dongsheng Gu,et al.  CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study , 2019, European Radiology.

[4]  Linquan Wu,et al.  Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality , 2019, BMC Cancer.

[5]  Prateek Prasanna,et al.  Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas. , 2019, Radiology.

[6]  Anant Madabhushi,et al.  Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings , 2018, Journal of magnetic resonance imaging : JMRI.

[7]  Joon Koo Han,et al.  Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis , 2018, Acta radiologica.

[8]  D. Sahani,et al.  Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. , 2017, AJR. American journal of roentgenology.

[9]  Tianxin Lin,et al.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer , 2017, Clinical Cancer Research.

[10]  Osamu Matsui,et al.  Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? , 2017, Japanese Journal of Radiology.

[11]  O. Paklina,et al.  Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. , 2017, Clinical radiology.

[12]  P Tiwari,et al.  Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study , 2016, American Journal of Neuroradiology.

[13]  Prateek Prasanna,et al.  Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor , 2016, Scientific Reports.

[14]  Ruijiang Li,et al.  Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy , 2016, Journal of magnetic resonance imaging : JMRI.

[15]  Yanqi Huang,et al.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Jeffrey,et al.  Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care. , 2016, Radiology.

[17]  A. Vanoli,et al.  The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories , 2016, Neuroendocrinology.

[18]  M. Kanda,et al.  Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography , 2016, Pancreas.

[19]  A. Krasinskas,et al.  The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms , 2015, The American journal of surgical pathology.

[20]  M. Büchler,et al.  Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. , 2015, Annals of surgery.

[21]  J. H. Kim,et al.  Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour , 2015, European Radiology.

[22]  N. Funel,et al.  Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours , 2015, European Radiology.

[23]  K. Moons,et al.  Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement , 2015, BJOG : an international journal of obstetrics and gynaecology.

[24]  A. Faggiano,et al.  Epidemiology of gastroenteropancreatic neuroendocrine tumours. , 2012, Best practice & research. Clinical gastroenterology.

[25]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[26]  M. Falconi,et al.  Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. , 2012, Gastrointestinal endoscopy.

[27]  A. Scarpa,et al.  TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. , 2012, Journal of the National Cancer Institute.

[28]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[29]  A. Scarpa,et al.  Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Ben Lawrence,et al.  The epidemiology of gastroenteropancreatic neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.

[31]  H. Imai,et al.  Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer , 2010, International Journal of Clinical Oncology.

[32]  J. Potter,et al.  Incidence rates of exocrine and endocrine pancreatic cancers in the United States , 2010, Cancer Causes & Control.

[33]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[34]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[35]  F. Zhu,et al.  Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. , 2019, Radiology.

[36]  H. Sorbye,et al.  Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.